These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2848692

  • 1. Human corticotropin-releasing hormone test in normal subjects and patients with hypothalamic, pituitary or adrenocortical disorders.
    Fukata J, Nakai Y, Imura H, Abe K, Aono T, Demura H, Fujita T, Hibi I, Ibayashi H, Igarashi M.
    Endocrinol Jpn; 1988 Jun; 35(3):491-502. PubMed ID: 2848692
    [Abstract] [Full Text] [Related]

  • 2. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 3. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 4. Corticotropin releasing factor (CRF): diagnostic implications.
    Müller OA, Stalla GK, Hartwimmer J, Schopohl J, von Werder K.
    Acta Neurochir (Wien); 1985 Dec; 75(1-4):49-59. PubMed ID: 2986422
    [Abstract] [Full Text] [Related]

  • 5. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 6. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M, Shibasaki T, Shizume K, Kiyosawa Y, Odagiri E, Suda T, Yamaguchi H, Tsushima T, Demura H, Maeda T.
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [Abstract] [Full Text] [Related]

  • 7. Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders.
    Tsukada T, Nakai Y, Koh T, Tsujii S, Inada M, Nishikawa M, Shinoda H, Kawai I, Takezawa N, Imura H.
    J Clin Endocrinol Metab; 1984 Apr; 58(4):758-60. PubMed ID: 6321536
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
    Tanaka T, Hibi I, Shimizu N, Imura H, Tanaka K, Fukata J, Fujieda K, Ichimura T, Kuribayashi T, Ito K.
    Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
    [Abstract] [Full Text] [Related]

  • 9. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H, Tamura T.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [Abstract] [Full Text] [Related]

  • 10. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP.
    Adv Biochem Psychopharmacol; 1987 Jun; 43():183-200. PubMed ID: 3035886
    [Abstract] [Full Text] [Related]

  • 11. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J, Shimizu N, Imura H, Hibi I, Tanaka K, Tanaka T, Nakagawa S, Takebe K, Kimura K, Yoshinaga K.
    Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
    [Abstract] [Full Text] [Related]

  • 12. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
    Lytras N, Grossman A, Perry L, Tomlin S, Wass JA, Coy DH, Schally AV, Rees LH, Besser GM.
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):71-84. PubMed ID: 6319053
    [Abstract] [Full Text] [Related]

  • 13. Correlation between plasma levels of ACTH and cortisol in basal states and during the CRH test in normal subjects and patients with hypothalamo-pituitary disorders.
    Bando H, Zhang CY, Takada Y, Takahashi H, Yamasaki R, Saito S.
    Tokushima J Exp Med; 1991 Dec; 38(3-4):61-9. PubMed ID: 1668824
    [Abstract] [Full Text] [Related]

  • 14. CRH and lysine-vasopressin stimulation tests in the diagnosis of hypoadrenalism secondary to hypothalamic or pituitary disorders.
    Cantalamessa L, Catania A, Baldini M, Orsatti A, Motta P, Peracchi G.
    Horm Metab Res; 1990 Jul; 22(7):389-93. PubMed ID: 2169450
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of corticotropin-releasing hormone in hypothalamic-pituitary-adrenal disorders and chronic renal failure.
    Hashimoto K, Nishioka T, Numata Y, Ogasa T, Kageyama J, Suemaru S.
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):503-7. PubMed ID: 8393256
    [Abstract] [Full Text] [Related]

  • 16. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P, Passini E, Re T, Faglia G, Ambrosi B.
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
    [Abstract] [Full Text] [Related]

  • 17. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
    Nieman LK, Cutler GB, Oldfield EH, Loriaux DL, Chrousos GP.
    J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ, Faria M, Newell-Price J, Browne P, Kopelman P, Coy DH, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [Abstract] [Full Text] [Related]

  • 19. Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone.
    Hensen J, Buhl M, Bähr V, Oelkers W.
    Klin Wochenschr; 1990 Jun 19; 68(12):608-14. PubMed ID: 2165544
    [Abstract] [Full Text] [Related]

  • 20. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B, Deuss U, Kaulen D, Leonhardt U, Kallabis D, Hamel E, Winkelmann W.
    J Clin Endocrinol Metab; 1986 Dec 19; 63(6):1427-31. PubMed ID: 3023423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.